AnGelHA 2 (502-01)

· Glyance

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AnGelHA 2 (502-01), covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Post-market Clinical Follow-up (PMCF) Study of Safety and Performance of 502-01 AnGelHA 2